Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: Etiology and prognostic factors

Critical Care

Volumn 15, Issue 4, 2011, Pages

  Chiang, Hou Hsien ^a   Hung, Chien Ching ^b   Lee, Chang Min ^b   Chen, Hsuan Yu ^c   Chen, Mao Yuan ^b   Sheng, Wang Huei ^b   Hsieh, Szu Min ^b   Sun, Hsin Yun ^b   Ho, Chao Chi ^b   Yu, Chong Jen ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; SERUM ALBUMIN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTENSIVE CARE; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SEPSIS; SURVIVAL RATE; TAIWAN; COMORBIDITY; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; MEDICAL AUDIT; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMORBIDITY; FEMALE; HIV INFECTIONS; HOSPITAL MORTALITY; HUMANS; IMMUNOCOMPROMISED HOST; INTENSIVE CARE UNITS; MALE; MEDICAL AUDIT; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PATIENT ADMISSION; PROGNOSIS; RESPIRATORY INSUFFICIENCY; SEPSIS; TAIWAN;

EID: 80052035219     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10419     Document Type: Article

References (34)

1. Huang L, Quartin A, Jones D, Havlir DV. Intensive care of patients with HIV infection. N Engl J Med 2006, 355:173-181. 10.1056/NEJMra050836, 16837681.
2. Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC, Oursler KK, Rimland D, Gibert CL, Butt AA, Justice AC. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011, 183:388-395. 10.1164/rccm.201006-0836OC, 20851926.
3. Morris A, Masur H, Huang L. Current issues in critical care of the human immunodeficiency virus-infected patient. Crit Care Med 2006, 34:42-49. 10.1097/01.CCM.0000194539.50905.81, 16374154.
4. Rosen MJ, Narasimhan M. Critical care of immunocompromised patients: human immunodeficiency virus. Crit Care Med 2006, 34(Suppl 9):245-250.
5. Rosenberg AL, Seneff MG, Atiyeh L, Wagner R, Bojanowski L, Zimmerman JE. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: Implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 2001, 29:548-556. 10.1097/00003246-200103000-00013, 11373418.
6. Gebo KA, Diener-West M, Moore RD. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001, 27:143-152.
7. Afessa B, Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 2000, 118:138-145. 10.1378/chest.118.1.138, 10893371.
8. Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L. Intensive care of human immunodeficiency virus infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002, 166:262-267. 10.1164/rccm.2111025, 12153955.
9. Narasimhan M, Posner AJ, DePalo VA, Mayo PH, Rosen MJ. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004, 125:1800-1804. 10.1378/chest.125.5.1800, 15136393.
10. Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004, 18:1429-1433. 10.1097/01.aids.0000131301.55204.a7, 15199319.
11. Nuesch R, Geigy N, Schaedler E, Battegay M. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV infected patients. Eur J Clin Microbiol Infect Dis 2002, 21:684-687. 10.1007/s10096-002-0792-3, 12373504.
12. Vincent B, Timsit JF, Auburtin M, Schortgen F, Bouadma L, Wolff M, Regnier B. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era. Intensive Care Med 2004, 30:859-866. 10.1007/s00134-004-2158-z, 14767592.
13. Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, Hogg E, Komarow L. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009, 4:e5575. 10.1371/journal.pone.0005575, 2680972, 19440326.
14. Vargas-Infante YA, Guerrero ML, Ruiz-Palacios GM, Soto-Ramírez LE, Del Río C, Carranza J, Domínguez-Cherit G, Sierra-Madero JG. Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res 2007, 38:827-833. 10.1016/j.arcmed.2007.05.007, 17923262.
15. Croda J, Croda MG, Neves A, De Sousa dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med 2009, 37:1605-1611. 10.1097/CCM.0b013e31819da8c7, 19325488.
16. Powell K, Davis JL, Morris AM, Chi A, Bensley MR, Huang L. Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest 2009, 135:11-17. 10.1378/chest.08-0980, 2742310, 18719058.
17. Barbier F, Coquet I, Legriel S, Pavie J, Darmon M, Mayaux J, Molina JM, Schlemmer B, Azoulay E. Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med 2009, 35:1678-1686. 10.1007/s00134-009-1559-4, 19575179.
18. Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J, Molina JM, Schlemmer B, Azoulay E. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 2010, 14:R107. 10.1186/cc9056, 2911753, 20534139.
19. Japiassú AM, Amâncio RT, Mesquita EC, Medeiros DM, Bernal HB, Nunes EP, Luz PM, Grinsztejn B, Bozza FA. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care 2010, 14:R152. 10.1186/cc9221, 2945136, 20698966.
20. Khouli H, Afrasiabi A, Shibli M, Hajal R, Barrett CR, Homel P. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 2005, 20:327-333.
21. . Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, Office of AIDS Research Advisory Council Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2007, Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, Office of AIDS Research Advisory Council., http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
23. Armbruster C, Pokieser L, Hassl A. Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients: comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction. Acta Cytol 1995, 39:1089-1093.
24. Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004, 350:2487-2498. 10.1056/NEJMra032588, 15190141.
25. Dickson SJ, Batson S, Copas AJ, Edwards SG, Singer M, Miller RF. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax 2007, 62:964-968. 10.1136/thx.2006.072256, 2117109, 17517829.
26. Hung CC, Hsiao CF, Chen MY, Hsieh SM, Chang SY, Sheng WH, Sun HY, Chang SC. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn J Infect Dis 2006, 59:222-228.
27. Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SY, Hsiao CF, Hung CC, Chang SC. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis 2006, 59:311-316.
28. Timsit JF. Open the intensive care unit doors to HIV-infected patients with sepsis. Crit Care 2005, 9:629-630. 10.1186/cc3923, 1414002, 16356250.
29. Mrus JM, Braun L, Yi MS, Linde-Zwirble WT, Johnston JA. Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care 2005, 9:R623-630. 10.1186/cc3811, 1378113, 16280060.
30. Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, . IeDEA Southern and Central Africa Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:251-261. 10.1016/S1473-3099(10)70026-8, 20334848, IeDEA Southern and Central Africa.
31. Wittkop L, Günthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C, Obel N, von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, García F, Judd A, Porter K, Thiébaut R, Castro H, van Sighem AI, Colin C, Kjaer J, Lundgren JD, Paredes R, Pozniak A, Clotet B, Phillips A, Pillay D, Chêne G, . The EuroCoord-CHAIN study group Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis 2011, 11:363-371. 10.1016/S1473-3099(11)70032-9, 21354861, The EuroCoord-CHAIN study group.
32. Chang SY, Chen MY, Lee CN, Sun HY, Ko W, Chang SF, Chang KL, Hsieh SM, Sheng WH, Liu WC, Wu CH, Kao CL, Hung CC, Chang SC. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. J Antimicrob Chemother 2008, 61:689-693. 10.1093/jac/dkn002, 18227088.
33. Yagi T, Kaneko T, Tsuruta R, Kasaoka S, Miyauchi T, Fujita M, Kawamura Y, Sakka SG, Maekawa T. Global end-diastolic volume, serum osmolarity, and albumin are risk factors for increased extravascular lung water. J Crit Care 2011, 26(2):224. e9-13.
34. Myburgh JA. The evidence for small-volume resuscitation with hyperoncotic albumin in critical illness. Crit Care 2008, 12:143. 10.1186/cc6882, 2447614, 18492216.